Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Scientific Industries, Inc.
13G/A
SCND · 808757108
|
10.0% |
11/13/2025
Event 9/30/2025
|
|||
| North Run Capital, LP | 10.0% | ||||
| North Run Advisors, LLC | 10.0% | ||||
| Todd B. Hammer | 10.0% | ||||
| Thomas B. Ellis | 10.0% | ||||
| Michael Bosco | 10.0% | ||||
| North Run - Due North Partners, LP | 10.0% | ||||
| North Run GP, LP | 10.0% | ||||
|
TELA Bio, Inc.
13G/A
TELA · 872381108
|
9.3% |
5/30/2025
Event 3/31/2025
|
|||
| North Run Capital, LP | 9.3% | ||||
| North Run Advisors, LLC | 9.3% | ||||
| North Run - Due North Partners, LP | 9.3% | ||||
| North Run GP, LP | 9.3% | ||||
| Todd B. Hammer | 9.3% | ||||
| Thomas B. Ellis | 9.3% | ||||
| Michael Bosco | 9.3% | ||||
|
LENSAR, Inc.
13D/A
LNSR · 52634L108
|
55.9% |
3/25/2025
Event 3/23/2025
|
|||
| North Run Capital, LP | 9.3% | ||||
| North Run Advisors, LLC | 9.3% | ||||
| NR-GRI Partners, LP | 51.1% | ||||
| NR-GRI Partners GP, LP | 51.1% | ||||
| Ellis Thomas B | 55.9% | ||||
| Hammer Todd B | 55.9% | ||||